Clinical profile of children with cerebral palsy born term compared with late- and post-term: a retrospective cohort

R Frank1, J Garfinkle2, M Oskoui2,3

  • 1Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Insights

Children with cerebral palsy (CP) born early/full-term had lower rates of neonatal encephalopathy but higher rates of neonatal hyperbilirubinemia compared to late/post-term births. However, overall CP outcomes were similar between groups.

Area of Science:

  • Neurology
  • Pediatrics
  • Perinatal Medicine

Background:

  • Cerebral palsy (CP) is a complex neurological disorder affecting movement and posture.
  • Gestational age at birth is a known risk factor for various neonatal complications and long-term neurodevelopmental outcomes.
  • Understanding differences in CP characteristics based on gestational age, particularly around term, is crucial for targeted interventions.

Purpose of the Study:

  • To investigate whether risk factors, neurological subtypes, severity, and comorbidities of cerebral palsy differ between children born early/full-term (37-40 weeks) and those born late/post-term (≥41 weeks).

Main Methods:

  • A retrospective cohort study utilizing data from the Canadian Cerebral Palsy Registry (CCPR) (n=802) of children born at 37 weeks gestation or later.
  • Children were categorized into early/full-term (37-40 weeks) and late/post-term (≥41 weeks) groups.
  • Comparisons of CP neurological subtype, Gross Motor Function Classification System (GMFCS) severity, risk factors, and comorbidities were made using chi-square or Fisher's exact tests.

Main Results:

  • Children born late/post-term exhibited higher rates of neonatal encephalopathy (33.6% vs 23.9%) and lower rates of neonatal hyperbilirubinemia (2.6% vs 10.2%) compared to early/full-term infants.
  • Apgar scores at 5 minutes were significantly higher in the early/full-term group.
  • No significant differences were observed in CP subtype, GMFCS severity, or comorbidities between the two gestational age groups.

Conclusions:

  • While specific neonatal complications like encephalopathy and hyperbilirubinemia differ between early/full-term and late/post-term births in children with CP, the overall clinical outcomes and severity of CP do not significantly vary.
  • These findings suggest that factors beyond immediate gestational age at term may play a more significant role in the long-term neurological impact of CP.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
636
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419